Publication | Open Access
LORIS robustly predicts patient outcomes with immune checkpoint blockade therapy using common clinical, pathologic and genomic features
88
Citations
41
References
2024
Year
Cancer ImmunosurveillanceAutoimmune DiseaseImmunologyTumor ImmunityPathologyPatient OutcomesImmune SurveillanceAutoimmunityImmune Checkpoint InhibitorImmune Cell TherapyImmunotherapyMedicineGenomic FeaturesImmunological Biomarkers
| Year | Citations | |
|---|---|---|
Page 1
Page 1